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Abstract
Gorlin’s or nevoid basal cell carcinoma syndrome (NBCCS) causes predisposition to basal cell carcinoma (BCC), the
commonest cancer in adult human. Mutations in the tumor suppressor gene PTCH1 are responsible for this autosomal
dominant syndrome. In NBCCS patients, as in the general population, ultraviolet exposure is a major risk factor for BCC
development. However these patients also develop BCCs in sun-protected areas of the skin, suggesting the existence of
other mechanisms for BCC predisposition in NBCCS patients. As increasing evidence supports the idea that the stroma
influences carcinoma development, we hypothesized that NBCCS fibroblasts could facilitate BCC occurence of the patients.
WT (n=3) and NBCCS fibroblasts bearing either nonsense (n=3) or missense (n=3) PTCH1 mutations were cultured in
dermal equivalents made of a collagen matrix and their transcriptomes were compared by whole genome microarray
analyses. Strikingly, NBCCS fibroblasts over-expressed mRNAs encoding pro-tumoral factors such as Matrix Metalloprotei-
nases 1 and 3 and tenascin C. They also over-expressed mRNA of pro-proliferative diffusible factors such as fibroblast
growth factor 7 and the stromal cell-derived factor 1 alpha, known for its expression in carcinoma associated fibroblasts.
These data indicate that the PTCH1
+/2 genotype of healthy NBCCS fibroblasts results in phenotypic traits highly reminiscent
of those of BCC associated fibroblasts, a clue to the yet mysterious proneness to non photo-exposed BCCs in NBCCS
patients.
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Introduction
Non melanocytic skin cancers are the most prevailing cancers in
human and 80 percent of them are basal cell carcinomas (BCCs)
[1,2]. BCC is the commonest cancer in adult human; its incidence
has been increasing constantly during the last 50 years in the
general population [3,4]. The Gorlin syndrome is an autosomal
dominant genetic disease, also named nevoid basal cell carcinoma
syndrome (NBCCS). NBCCS is associated to a dramatic
predisposition to BCCs (up to hundreds) [5]. Other clinical
features include various developmental traits and, in 3 to 5 percent
patients, susceptibility to medulloblastoma. In 1996, mutations in
the tumor suppressor gene PATCHED (PTCH1) were found to be
associated to NBCCS [6,7]. Most PTCH1 germinal mutations lead
to premature stop codon [8], and in BCCs, are accompanied by
somatic mutations or loss of heterozygosity (LOH) at the PTCH1
locus (9q22.3) [9,10], as expected for a tumor suppressor gene
[11]. In sporadic BCCs somatic mutations in PTCH1 have been
reported in up to 67% of cases; most of them correspond to
ultraviolet fingerprints, CRT and CCRTT transitions [12–14].
Sporadic BCCs also display frequent (93% cases) LOH of the
PTCH1 locus [15,16].
The PATCHED protein acts as the receptor of the diffusible
morphogen SONIC HEDGEHOG (SHH). Binding of SHH to
PATCHED relieves its inhibitory effect on the pathway activation,
leading to the transcription of target genes including PTCH1 itself
and glioma-associated oncogene homolog transcription factors 1
and 2 (GLI1/2).
Bi-allelic inactivating mutations of PTCH1 in both sporadic and
NBCCS BCCs presumably lead to SHH-independent constitutive
activation of the pathway as suggested by over-expression of the
targets genes, PTCH1 itself and GLI1 [12,17–20]. Thus, loss of
control of the SHH pathway appears as a hallmark of BCC.
Together, these observations underline the essential role of
maintenance of the SHH pathway in human skin homeostasis.
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4818In the general population BCCs develop almost exclusively in
sun-exposed areas of the skin [2]. In contrast, and, intriguingly,
NBCCS BCCs are observed in both sun-protected and sun-
exposed areas. Interestingly, our previous studies have shown that
both fibroblasts and keratinocytes from NBCCS patients exhibit
normal nucleotide excision repair of UVB-induced DNA lesions
and survival capacities following a single UVB irradiation [21].
These data suggest that solar UVs are far from being the only
etiologic factor of BCC in NBCCS patients. Other mechanisms
such as altered dermo-epidermal interactions could contribute to
development of NBCCS BCC in non photo-exposed skin [22].
More and more evidence accumulates indicating the role of the
stroma in tumoral development in general [23], and in the
particular case of BCC as well.
Here, we hypothesized that NBCCS fibroblasts could exhibit
features determinant towards BCC development. We compared
the genome expression of NBCCS primary fibroblasts cultured in
a dermal equivalent to that of control fibroblasts under the same
circumstances. Results indicate that essential factors for BCC
development, such as MMP1, MMP3, CXCL12, ANGPTL2,
MGP, TNC, and SFRP2 are over-expressed by NBCCS
fibroblasts. Hence, heterozygous PTCH1 mutations may result
in expression of genes whose stromal expression is associated
with (skin) cancer development. Our data strongly suggest that
NBCCS fibroblasts could play a prominent role in predisposi-
tion of patients towards BCCs, including in sun-protected skin
areas.
Results
Whole genome microarray comparison of control and
NBCCS fibroblasts transcriptomes
We compared the genome wide expression profile of 9 primary
independent fibroblasts strains cultured in dermal equivalents
(CTRL, n=3; NBCCS, n=6). Three NBCCS fibroblast strains
bore missense mutations and 3 bore nonsense mutations in the
PTCH1 gene. Total RNAs were extracted from the dermal
equivalents and gathered in 3 pools according to the genetic status
of PTCH1 (WT; missense and nonsense PTCH1 mutations). The
transcription profile of the control pool was compared to that of
each NBCCS pool, on AgilentH human whole genome oligo
microarray. Results were analyzed with the Rosetta ResolverH
system for gene expression analysis [24].
Results of this genomic screen are available in the database
ArrayExpress (accession number: E-TABM-549). To select the
genes with a high probability to be differentially expressed in the
NBCCS pools, the threshold for the p-value was set to 10
25. 182
genes were found up-regulated and 126 down-regulated (p-
value,10
25) in both the missense and the nonsense pools (Table
S1). These 308 genes of the common signature displayed a high
correlation between the two NBCCS pools (correlation coefficient
of 0.929) (Figure 1). Only 6 probes corresponding to 5 genes were
anti-correlated, i.e. up-regulated in one NBCCS pool and down-
regulated in the other one (CILP, LY6K, CLEC3B, CYP1B1 and
LEPROT; Table S2). For all the primary sequences, an analysis of
variance (ANOVA) of the logarithm of the ratio of the intensities
in each NBCCS pool to the WT pool was performed. Cluster
analysis was done on the ANOVA results. 38 genes, including the
5 anti-correlated genes, with different levels of expression in the
two NBCCS pools are listed and clustered in Figure S1 and Table
S3. These data indicate for the first time that missense or nonsense
mutations of PTCH1 have overall very similar consequences on
the transcriptome of dermal fibroblasts.
Then, we focused more precisely on the genes whose mRNAs
amounts were increased by at least 2.1 in both the missense and
the nonsense pools (Table 1).
Over-expression of pro-tumoral matrix
metalloproteinases and modified expression of
extracellular matrix and basement membrane
components in NBCCS fibroblasts
By applying SBIME (Searching for a Biological Interpretation
of Microarray Experiments) [25] to the data with the Gene
Ontology annotations, we found that genes involved in the
extracellular matrix composition or remodeling, and genes
involved in cell adhesion were overrepresented in the signature
Figure 1. Comparison plot of the missense and the nonsense signatures revealed by the microarray analysis. All the genes with
statistically (p,10
25) different mRNA level between any NBCCS pool and the control pool are plotted. In abscissa: the logarithm of the ratio of the
intensities in the missense and the control pools. In ordinate: the logarithm of the ratio of the intensities in the nonsense and the control pools. Note
the correlation between the missense (MS) signature and the nonsense (NS) signature revealed by the linear shape of the common signature
(correlation coefficient of 0.929).
doi:10.1371/journal.pone.0004818.g001
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Primary Sequence Name Accession Number missense pool nonsense pool NBCCS
Fold Increase p-value Fold Increase p-value Fold Increase p-value
MMP3 NM_002422 19.7421 0 13.0139 0 15.931 0
ALDH1A3 NM_000693 5.92 0 10.883 0 6.799 1.61E-34
KCNJ8 NM_004982 12.2448 0 10.1035 5.14E-32 11.282 0
MMP1 NM_002421 8.4122 0 7.8028 0 8.174 0
CLIC6 NM_053277 18.5676 1.72E-35 7.711 3.54E-13 17.042 3.64E-31
COL11A1 NM_080629 9.7967 9.06E-22 5.4611 4.28E-14 10.146 2.21E-12
IL13RA2 NM_000640 8.9084 0 4.6296 2.00E-19 6.822 1.52E-23
DHRS3 NM_004753 4.3342 0 3.7553 3.85E-33 4.409 0
APBB1IP NM_019043 4.6804 0 3.7532 2.47E-40 4.209 0
MASP1 NM_139125 3.2252 1.34E-21 3.421 3.33E-18 3.245 4.03E-21
BX537788 BX537788 4.3842 9.63E-37 3.408 1.22E-15 4.197 4.80E-19
SPOCK1 NM_004598 3.1251 0 3.3341 0 3.376 0
ANGPTL4 NM_139314 7.5098 0 3.1122 0 4.353 1.07E-10
GHR NM_000163 4.5814 9.60E-26 3.0934 4.03E-06 4.065 5.44E-16
KCTD15 NM_024076 3.0865 1.44E-21 3.0498 1.42E-19 3.069 0
AI476245 AI476245 5.1206 0 3.0481 3.41E-17 4.46 4.73E-33
AF264625 AF264625 2.8355 7.77E-28 2.8518 2.37E-25 2.918 0
SMOC2 NM_022138 5.5702 6.90E-20 2.788 4.85E-06 5.133 2.20E-13
FLJ14834 NM_032849 5.8414 0 2.7641 6.60E-32 3.872 1.26E-11
MGC42157 BC030111 2.9857 0 2.759 1.59E-22 2.986 0
PTGIS NM_000961 2.8252 5.37E-22 2.7335 2.82E-23 2.882 1.10E-42
NANOS1 NM_199461 3.609 3.75E-13 2.6956 5.74E-12 2.696 5.75E-12
DPP3 NM_130443 2.6339 8.64E-18 2.6929 3.39E-17 2.663 5.37E-38
CXCL12 NM_199168 2.8062 1.10E-34 2.5629 5.33E-25 2.695 7.25E-38
MGST1 NM_145791 3.9293 0 2.5332 2.55E-24 2.903 1.35E-13
SNCA NM_007308 3.0297 3.71E-30 2.5018 7.41E-09 2.853 1.17E-26
PRL NM_000948 5.4189 0 2.484 2.42E-15 4.168 1.90E-11
ADARB1 NM_015833 2.2018 6.96E-29 2.4494 6.38E-38 2.333 0
AKR1C1 NM_001353 2.8523 5.59E-37 2.4218 7.18E-21 2.53 1.65E-29
CCRL1 NM_178445 2.3757 1.12E-18 2.4162 1.81E-26 2.484 0
BC035260 BC035260 2.1041 3.96E-12 2.4093 6.50E-09 2.189 2.68E-21
AA417913 AA417913 2.37 3.52E-19 2.409 1.49E-29 2.429 5.32E-38
TFPI2 AK129833 6.1688 4.05E-40 2.4071 1.13E-06 5.176 3.85E-11
GPC6 BX640888 3.4137 7.47E-36 2.405 7.60E-21 2.627 2.08E-22
DSCR1 NM_004414 2.2516 1.42E-10 2.4037 1.24E-11 2.322 3.13E-22
STEAP1 NM_012449 2.9091 0 2.3808 7.46E-35 2.545 8.36E-35
AKR1C3 NM_003739 2.3671 8.04E-21 2.3569 7.55E-24 2.362 0
AKR1C1 NM_001353 2.8883 0 2.3474 1.23E-39 2.682 4.93E-13
CMTM1 NM_181289 2.3129 3.71E-31 2.3448 1.11E-25 2.368 0
EXOSC6 NM_058219 2.2792 0 2.3187 1.12E-44 2.275 0
HSPA5BP1 NM_017870 2.8592 5.23E-18 2.2717 4.12E-15 2.354 1.88E-30
CDON AK022986 2.6989 2.02E-19 2.2717 1.60E-08 2.452 5.46E-14
STEAP2 NM_152999 2.8101 7.94E-37 2.2325 1.10E-09 2.714 0
PPAP2A NM_176895 3.5108 6.87E-38 2.23 1.83E-35 2.49 3.14E-16
STEAP1 NM_012449 2.8538 0 2.2024 2.10E-39 2.392 3.50E-23
CPM NM_001874 3.715 0 2.1577 1.14E-25 3.001 3.31E-11
NR4A3 NM_173200 4.2339 0 2.1442 3.44E-11 3.204 2.21E-10
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(MMP3; stromelysin 1) exhibited the highest increased level in
both NBCCS pools. MMP3 mRNA increased by 19.7 and 13 in
the missense and the nonsense pools, respectively, compared to the
control pool (Table 1). mRNA of the matrix metalloproteinase 1
(MMP1; collagenase 1) increased by 8.4 and 7.8 in the missense
and the nonsense pools, respectively (Table 1).
To confirm microarray results, reverse transcription and
quantitative polymerase chain reactions (RT-QPCR) were per-
formed on each mRNA sample extracted from the 3 control and 6
NBCCS fibroblast primary strains used in the genomic screen.
The average MMP3 and MMP1 mRNA levels were found
statistically increased by 26.84 and 8.43, respectively, in NBCCS
compared to control fibroblasts (p,0.025 for both MMP3 and
MMP1) (Table 2). We also noticed by ELISA increased levels of
MMP1 and MMP3 secreted proteins in culture supernatants of
NBCCS dermal equivalents by 10.9 and 2.1 respectively (Figure 2).
These findings indicate that MMP3 and MMP1 mRNA increases
result in over-production and secretion of their respective protein.
The mRNAs of some of the components of the extracellular
matrix (ECM) were also found up-regulated in the missense and
the nonsense NBCCS pools. For instance, the amount of collagen
type 11 alpha 1 (COL11A1) mRNA was increased by 9.8 and 5.5
and tenascin C (TNC) mRNA was increased by 1.4 and 1.3 in the









CTRL1 CTRL2 CTRL3 NBCCS1 NBCCS7 NBCCS8 NBCCS3 NBCCS6 NBCCS10
MMP1 1 1.3 3.62 10.39 30.98 5.17 24.82 23.65 4.9 8.43 p,0.025
MMP3 1 0.89 2.32 40.98 77.08 30.01 16.18 45.77 16.45 26.84 p,0.025
COL3A1 1 0.64 0.67 0.35 0.53 0.6 0.25 0.54 0.81 0.66 p#0.05
COL7A1 1 1.67 1.45 0.45 0.57 0.74 1.38 0.48 1.19 0.58 p#0.05
COL11A1 1 0.11 1.99 15.93 5.62 22.91 0.02 10.93 15.73 11.47 NS
LAMA2 1 0.57 0.54 0.34 0.25 0.34 0.21 0.32 0.34 0.43 p,0.025
TNC 1 1.03 0.99 1.46 1.29 1.27 0.61 0.77 2 1.22 NS
CXCL12 1 1.13 1.22 2.46 2.77 2.48 1.77 4.24 2.31 2.39 p,0.025
MGP 1 0.01 0.18 4.67 1.38 2.65 0.27 1.28 2.11 5.19 p,0.025
ANGPTL2 1 0.98 0.93 3.32 2.09 3.21 1.16 3.78 3.67 2.95 p,0.025
ANGPTL4 1 0.8 0.79 12.24 7.2 15.1 2.08 10.18 3.75 9.77 p,0.025
FGF7 1 1.76 2.07 4.56 2.63 4.48 1.32 5.09 3.75 2.26 p#0.05
GREM1 1 2.03 4.54 3.86 1.57 8.36 1.92 5.73 4.25 1.7 NS
SFRP2 1 0.65 0.49 1.66 0.73 4.04 1.6 2.71 4.08 3.46 p,0.025
DKK3 1 0.58 1.06 0.1 0.21 0.13 0.38 0.19 0.36 0.26 p,0.025
WNT5A 1 0.98 1.89 0.52 0.39 1.05 0.42 0.74 0.69 0.5 p#0.05
WISP2 1 0.35 0.32 0.71 2.08 1.73 0.77 1.94 1.93 2.74 p#0.05
ID2 1 1.26 2.92 3.39 3.65 7.26 1.38 8.27 3.2 2.62 p,0.025
*The level of mRNA of the indicated genes was measured by RT-QPCR on the mRNAs extracted from each dermal equivalent used for the microarray assay (CTRL: n=3;
NBCCS: n=6). Results were normalized and set to 1 for the mRNA from the dermal equivalent with control fibroblast strain 1. The ratios between the average mRNA
levels in the NBCCS and the control fibroblasts and the p-value are indicated. NS: not significant (p.0.05).
doi:10.1371/journal.pone.0004818.t002
Primary Sequence Name Accession Number missense pool nonsense pool NBCCS
Fold Increase p-value Fold Increase p-value Fold Increase p-value
CA12 NM_001218 2.9836 0 2.1333 0 2.344 6.78E-19
PCSK5 NM_006200 3.4846 0 2.1278 1.36E-09 2.602 2.16E-08
WISP2 NM_003881 2.5103 1.30E-23 2.1266 6.04E-18 2.185 2.91E-35
SAA1 NM_000331 3.048 0 2.1112 1.25E-21 2.343 4.35E-16
*List of the 51 genes, with their OMIM accession number associated, whose mRNA levels were increased more than 2.1 fold in the missense and the nonsense pools. In
the two NBCCS pools, for each gene, the fold increase compared to the control pool and its p-value are mentioned. The average NBCCS level was determined by
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S1). RT-QPCR confirmed the increased level of COL11A1 mRNA
in 5 of the 6 NBCCS fibroblasts compared to control fibroblasts.
The average rate of COL11A1 mRNA over-expression in NBCCS
fibroblasts was 11.47 (Table 2). The slight increased level of TNC
mRNA was confirmed by RT-QPCR (1.22 fold; Table 2) and
immunohistochemistry performed on organotypic skin cultures
comprising fibroblasts isolated from two independent NBCSS
patients studied here revealed a stronger TNC over-expression
(Figure 3).
The mRNA levels of some components of the basement
membrane were decreased in the missense and the nonsense
NBCCS pools. Collagen type 3 alpha 1 (COL3A1) were decreased
by 1.4 and 1.5 in the missense and the nonsense pools, respectively
(Table S1). Similarly the collagen type 7 alpha 1 (COL7A1) mRNA
level was decreased by 1.8 and 1.3 in the two NBCCS pools (Table
S1 and in ArrayExpress). The mRNA level of the laminin alpha 2
(LAMA2) was also decreased by 1.5 and 1.4 respectively in the
missense and the nonsense pool (Table S1). RT-QPCR confirmed
the decreased average mRNA amounts of COL3A1, COL7A1, and
LAMA2 by 1.52, 1.72 and 2.33 respectively (p#0.05; p#0.05;
p,0.025), in NBCCS compared to control fibroblasts (Table 2).
Together these results indicate that some ECM and basement
membrane components are expressed differentially between
NBCCS and control fibroblasts under organotypic culture
conditions.
NBCCS fibroblasts over-express the BMP antagonist
GREMLIN1, growth factor and cytokines associated with
BCC stroma
The mRNA levels of chemokine (C-X-C motif) ligand 12
(CXCL12; stromal-cell derived factor 1 alpha) and of the bone
morphogenetic protein (BMP) antagonist GREMLIN1 (GREM1)
were found up-regulated in our microarray analysis, as well as
those of angiopoietin like 2 and 4 (ANGPTL2; ANGPTL4), matrix
GLA protein (MGP) and fibroblast growth factor 7 (FGF7;
keratinocyte growth factor). The mRNA level increases, in the
missense and the nonsense pools, were respectively 2.8 and 2.6 for
CXCL12, 7.5 and 3.1 for ANGPTL4 (Table 1). Similarly, the
increases of MGP mRNA levels were 2 and 1.4 in the missense and
the nonsense pools respectively, 2 and 1.7 for ANGPTL2, 1.9 and
1.7 for GREM1 and finally 2.3 and 1.6 for FGF7 (Table S1).
RT-QPCR confirmed that CXCL12, MGP, ANGPTL2,
ANGPTL4 and FGF7 average mRNA levels were increased in
NBCCS fibroblasts by 2.39, 5.19, 2.95, 9.77 and 2.26 respectively
(p,0.025 for each; Table 2). ANGPTL4 mRNA level was higher in
fibroblasts of the missense pool than in fibroblasts of the nonsense
pool. The increase of GREM1 mRNA level in NBCCS fibroblasts
did not reach statistical significance.
Figure 3. NBCCS fibroblasts in organotypic cultures over-express TNC. Organotypic skin cultures with control keratinocytes and the
indicated fibroblasts were developed and 5 mm paraffin sections were immunolabelled using anti-human TNC antibody. Note the barely detectable
labelling of TNC in control dermis and its increase in both NBCCS fibroblast strains tested (6 and 10).
doi:10.1371/journal.pone.0004818.g003
Figure 2. NBCCS fibroblasts in dermal equivalents over-
express MMP1, MMP3 and FGF7. The levels of secreted MMP1,
MMP3 and FGF7 were determined by ELISA in the supernatants of the
dermal equivalents used for the microarray assay. Results were set to 1
for the protein levels in the supernatant of the dermal equivalent with
control (CTRL) fibroblast strain 1. The protein level in control strains is
represented with grey histogram and with black histogram in NBCCS
strains. The average MMPs and FGF7 levels in the supernatants of
control (NBCCS) dermal equivalents are indicated with a plain (dotted)
line. The ratios between the average protein levels in NBCCS and in
control fibroblasts are indicated (arrow).
doi:10.1371/journal.pone.0004818.g002
CAF Features in Fibroblasts
PLoS ONE | www.plosone.org 5 March 2009 | Volume 4 | Issue 3 | e4818These mRNA over-expressions were correlated with increased
levels of protein as confirmed by western blot analysis on cellular
extracts for CXCL12 (4.4 average fold increase; p#0.05) (Figure 4)
and by ELISA on the supernatant of dermal equivalents for FGF7
(1.7 fold increase) (Figure 2).
The WNT/beta catenin pathway in NBCCS fibroblasts
The WNT/beta catenin pathway plays a crucial role in the
regulation of proliferation and differentiation of keratinocytes [26].
In BCCs, nuclear beta catenin staining, corresponding to pathway
activation, has been observed and associated with increased
proliferation [27,28]. Among the secreted inhibitors of the WNT/
beta catenin pathway, Dickkopf 1 (DKK1), secreted frizzed related
protein 1 (SFRP1), SFRP2, and WNT inhibitory factor 1 (WIF1)
were up-regulated while DKK3 was down-regulated (Table S1 and
in ArrayExpress). RT-QPCR confirmed the increased level of
SFRP2 mRNA (by 3.46; p,0.025) and the decreased level of
DKK3 mRNA (by 3.85; p,0.05) in NBCCS fibroblasts (Table 2).
WNT5A mRNA, which encodes a ligand of the non canonical
WNT pathway, was down-regulated by 2.9 and 2.7 in the missense
and the nonsense pool respectively (Table S1). A significant
decreased level in NBCCS fibroblasts was confirmed by RT-
QPCR (average 2.0 fold decrease; p#0.05; Table 2).
The mRNA levels of two target genes of WNT, WNT1
Inducible Signaling Pathway Protein 2 (WISP2) and Inhibitor of
DNA Binding 2 (ID2) were increased in both NBCCS pools
(Table 1 and Table S1). RT-QPCR confirmed that WISP2 and
ID2 mRNA levels were significantly increased by 2.74 (p#0.05)
and 2.62 (p,0.025) respectively in NBCCS fibroblasts (Table 2).
Discussion
The study of carcinoma development has long been mainly
focused on tumor suppressor genes mutations and proto-oncogenes
activations in tumor cells. However, increasing evidence has
indicated that tumor-stroma interactions regulate tumoral growth
and invasiveness, and contribute to metastasis as reviewed in [29–
31]. In the case of BCCs, the stroma seems to be essential for the
survival of cancer cells. Indeed, by contrast to squamous cell
carcinomacells,BCCcellscanhardlybeculturedexvivo,and exhibit
virtually null metastatic potential in vivo [32]. Grafting experiments
have shown that growth of BCC cells depends on the presence of
their carcinoma associated fibroblasts (CAF) [33,34]. In the present
study, using whole genome transcriptome analyses, we have
investigated the extent to which PTCH1
+/2 dermal fibroblasts
could contribute to BCC development providing that NBCCS
tumors also develop in non photo-exposed skin areas, i.e. in the
absence of external genotoxic stress. Although isolated from healthy
skin of patients, NBCCS fibroblasts exhibit features very close to
those of BCC-associated fibroblasts from non NBCCS individuals.
Perhaps, the most intriguing observation of our genomic screen
was that none of the members of the SHH pathway was
differentially expressed in NBCCS compared to control fibro-
blasts. In vertebrates, skin homeostasis relies on a balanced dialog
between dermal and epidermal cells [35–37]. Experimental
models suggest that the SHH pathway is involved not only in
the development and cycle of hair follicles [38] but also in the
regulation of recruitment and proliferation of interfollicular
epidermal stem cells [39,40]. Loss of control and activation of
the SHH pathway was found in all BCCs tested [12,17–20]. Thus,
beyond its evident role in the control of growth of epidermal cells,
proper control of the SHH pathway could also contribute to
dermo-epidermal interactions, a hypothesis fitting well with distal
transmission of the SHH signal between expressing and receiving
cells [41] and with growth features of BCC cells as well.
As for members of the SHH pathway, our results did not
contribute to a clear conclusion on either activation or inhibition
of the WNT pathway in NBCCS fibroblasts. Increased mRNAs
levels of SFRP2 and WNT5A, have been found in CAF of BCC
[42] and in whole BCC [43] respectively. SFRP2 mRNA was also
found increased in our screen. In contrast, mRNA amounts of
WNT5A and of DKK3 which encodes another inhibitor of the
WNT pathway were decreased (Table 2). Some target genes of the
WNT pathway, WISP2 and ID2 were up-regulated (Table 2) while
others such as C-MYC and CYCLIN D1 were not. WISP2 has been
shown to be strongly expressed in the stroma of breast tumors in
Wnt1-transgenic mice [44]. ID2 was over-expressed in human
colorectal carcinomas [45].
The absence of epidermal cells in our experimental settings may
perhaps explain why, first, target genes of the SHH pathway were
not found differentially expressed in NBCCS compared to control
fibroblasts and second, the non-conclusive pictures drawn from
study of the WNT pathway. Rather, our screening strategy may
reflect cell autonomous impact of heterozygous PTCH1 mutations
in mesenchymal cells. Future experiments in the presence of both
fibroblasts and keratinocytes should shed light on these issues.
For the first time, comparison of the whole genome expression
in NBCCS and control fibroblasts clearly reveals a signature
including several genes known for their association with tumor
growth and invasiveness. A previous study reported over-
expression of MMP3 but not of MMP1 mRNAs in cultured
NBCCS fibroblasts and NBCCS BCCs [46]. Here, increases in
MMP3 and MMP1 mRNAs and proteins amounts, were reported
in NBCCS fibroblasts cultured in dermal equivalents (Table 2 and
Figure 4. NBCCS fibroblasts over-express CXCL12. Western blot
analysis of CXCL12 was performed on cellular extracts of the 3 control
(CTRL) and 6 NBCCS fibroblast strains. GAPDH was used as a loading
control. The level of CXCL12 was normalized to the GAPDH level and
was set to 1 in the control fibroblasts strain 1. A representative western
blot and quantification from 3 independent experiments are repre-
sented. Error bars refer to standard errors. The protein level in control
strains is represented with grey histogram and with black histogram in
NBCCS strains. The average CXCL12 level in control (NBCCS) fibroblasts
is indicated with a plain (dotted) line (*: p#0.05). The ratio between the
average mRNA level in NBCCS and in control fibroblasts is indicated
(arrow).
doi:10.1371/journal.pone.0004818.g004
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reported in CAF of sporadic BCCs [47,48]. MMP1 over-
expression was also observed in dermal fibroblasts from xeroderma
pigmentosum group C patients and is thought to be involved in
skin cancer development in these patients [49]. Epidermal over-
expression of MMP1 in transgenic mice induces epidermal
hyperplasia [50]. Also, MMP3 over-expression in mouse mam-
mary epithelial cell line stimulates the epithelial to mesenchyme
transition and invasiveness [51]. Most interestingly, a recent report
from Dr. Bissell’s laboratory indicated that MMP3-induced
epithelial to mesenchyme transition and genomic instability are
mediated through increased production of reactive oxygen species
[52]. Since, first, MMP1 processing is in part dependent on
MMP3, second, these MMPs present partially distinct substrate
specificities, and, third, none of their tissue inhibitors was found
over-expressed, concomitant increases of MMP1 and MMP3 in
patients’ fibroblasts strongly argue for a prominent role of the
mesenchyme in BCC development and invasiveness in NBCCS.
NBCCS fibroblasts also over-expressed the pro-tumoral ECM
component TNC (by 1.22, Table 2; Figure 3). TNC was found
strongly expressed in the stroma of BCCs [53] and can up-regulate
MMP3 expression [54]. Interestingly, TNC is a proteolysis
substrate of MMP1 and MMP3 [55]. In addition, TNC contains
EGF-like repeats whose binding to the EGF receptor stimulates
mitogenesis [56]. Our study also shows that mRNA amounts of
CXCL12, GREM1 and FGF7 (Table 2, Figure 2 and Figure 4) were
also significantly increased in NBCCS fibroblasts. CXCL12 is
expressed by CAF of BCC, is involved in the invasion of BCC
cells [57] and can also recruit endothelial cells [58,59]. GREM1
over-expression is associated with BCC stromal cells and promotes
BCC cells proliferation [60]. FGF7 (keratinocyte growth factor)
has a mitogenic activity in keratinocytes [61]. In NBCCS patients,
presence of high levels of MMP1 and MMP3, as well as growth
regulatory factors such as TNC, CXCL12, GREM1 and FGF7
could stimulate proliferation of BCC cells and elicit invasiveness.
COL11A1 mRNA was also found increased in NBCCS
fibroblasts, an observation reminiscent of its over-expression by
stromal fibroblasts in human colorectal tumors [62]. In contrast
lower amounts of mRNAs of the basement membrane compo-
nents COL3A1, COL7A1 and LAMA2 [63] (Table 2) could be
responsible for loosening basement membrane and, hence,
facilitate local aggressiveness of pre-tumoral (PTCH1
+/2 keratino-
cytes) or tumoral epidermal cells [22].
Finally, the 3 times increased mRNA level of ANGPTL2 which
encodes a member of the angiopoietin-like family (Table 2), could
reflect pro-angiogenic properties as suggested by its effects on
endothelial cells sprouting [64]. However, it was noteworthy that
one of the most over-expressed mRNA by NBCCS fibroblasts in
this study was ANGPTL4 (9.7 fold increase; Table 1 and Table 2).
ANGPTL4 can inhibit tumor cells (B16F0) motility and
invasiveness [65] and exhibit anti-angiogenic properties [66].
Whether less vascularization [67] and very low metastatic
potential of BCC compared to squamous cell carcinomas could
be related to high levels of ANGPTL4 requires further
investigations. Our data are in excellent agreement with those
recently obtained by transcriptome analyses of CAF from BCC
compared to perifollicular dermal fibroblasts [42]. In this study,
the authors found that SFRP2, ANGPTL2, and CXCL12 mRNA
amounts were increased in CAF of BCC.
In summary, even if the causal link between PTCH1
+/2 genetic
status and abnormal expression of genes reported here remains to
be clarified, our data clearly converge towards a global trend of
NBCCS dermal fibroblasts to express some characteristics of CAF
from BCCs. Modified expressions of ECM and basement
membrane components, which are also observed in the stroma
of BCCs [68], suggest that dermal fibroblasts might also produce a
BCC facilitating microenvironment in NBCCS patients. Impor-
tantly, all primary fibroblasts used in this study were isolated from
biopsies of healthy and photo-protected skin and gave very similar
results irrespective of the type of PTCH1 mutation. Altogether,
these results strongly suggest the involvement of dermal fibroblasts
in BCC predisposition in NBCCS patients including in non photo-
exposed skin areas. In addition, NBCCS keratinocytes from the
same NBCCS patients exhibit spontaneous invasive properties in
dermal equivalents populated with control fibroblasts [22]. More
investigations must now be carried out in the long term to
determine the extent to which NBCCS fibroblasts may affect the
fate of epidermal keratinocytes. Also it would be essential to verify
the present results in healthy, non photo exposed skin of NBCCS
patient. Future studies should lead to improved approaches, taking
into account the role of fibroblasts, in BCC prevention and/or
treatment, not only in NBCCS patients but also in the general
population.
Materials and Methods
Ethics Statement - Patients and cells
This study was approved by a local French ethic committee
(CCPPRB: CSET935) and was conducted after informed written
consent of NBCCS patients. Skin biopsies from NBCCS and
control persons were taken from sun-protected healthy areas.
NBCCS patients 1, 7 and 8 harbour independent missense
mutations in PTCH1; NBCCS patients 3, 6 and 10 harbour
nonsense independent mutations in PTCH1. NBCCS patients are
described in [21] and in ArrayExpress. From these patients,
primary dermal fibroblasts were cultured as described before [69].
Experiments were performed using cells at passages 5 to 9.
Dermal equivalents and organotypic skin cultures
All fibroblasts (WT n=3; NBCCS n=6) were cultured in a
tridimensional type I collagen matrix called dermal equivalent.
Dermal equivalents and organotypic skin cultures were cultured in
immersion and then at the air-liquid interface as described in [70].
For dermal equivalents keratinocytes were replaced by culture
medium. Organotypic skin cultures were realized using control
keratinocytes at passage 5 with CTRL1, NBCCS6 or NBCCS10
fibroblasts strains. These NBCCS strains, bearing independent
nonsense mutations in PTCH1, were chosen as they are
representative of the major type of mutation occurring in NBCCS
patients.
RNA extraction
Dermal equivalents were snap frozen in liquid nitrogen, ground
to powder and then solubilized in TRIzol reagent (Invitrogen,
Carlsbad, USA, CA). Then chloroform was added and the
aqueous phase was removed. Total RNAs were precipitated in
isopropanol and washed twice before being resuspended in
nuclease free water. Total RNAs were purified using the RNA
cleanup and concentration kit (QIAGEN, Hilden, Germany) and
gathered in 3 pools according to the genetic status of PTCH1 (WT;
missense and nonsense PTCH mutations).
Whole genome microarray analysis
Protocol is detailed in ArrayExpress (accession number: E-
TABM-549). The mRNA pools were labelled using fluorescent
low input linear amplification kit (Agilent, Santa Clara, USA,
CA). Briefly, reverse transcription was performed using MMLV
reverse transcriptase. Then, cyanine 3 or 5 labeled cRNAs were
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carried out for 17 hours at 60uC with 1 mg of purified control
and NBCCS probes on AgilentH human whole genome oligo
microarray 44k. Slides were scanned using an Agilent 2565 AB
DNAmicroarray scanner. Microarray images were analysed by
using Feature extraction software version A.8.5.1.1. (Agilent).
Raw data files were then imported into ResolverH system for
gene expression data analysis (Rosetta Inpharmatics LLC,
Seattle, USA, WA).
RT-QPCR
Reverse transcription and quantitative real time PCR were
performed as described in [22], using the specific primers detailed
in supplementary Table S4. B2M, TBP, GAPDH, RPLO1 and
PPIA were used as housekeeping genes. Results of the Q-PCR
were normalized using the geNorm software (http://medgen.
ugent.be/,jvdesomp/genorm/). A Mann-Whitney test was used
to determine whether the levels of mRNA in the 3 control and 6
NBCCS dermal equivalents were statistically different.
ELISA
MMP1 and MMP3 levels in the supernatant of the dermal
equivalents were measured using the human biotrak assays
(RPN2610 and RPN 2613, GE Healthcare, London, UK).
FGF7 level was determined using the Human KGF Immunoassay
(DKG00, R&D Systems, Minneapolis, Minnesota), according to
the manufacturers’ protocols.
Immunohistochemistry
Tenascin C immunostainings were done on 5 mm paraffin
sections of skin organotypic cultures with control keratinocytes
and either CTRL1, NBCCS6 or NBCCS10, using the Discovery
XT automated stainer (Ventana Medical Systems), with
3,39-diaminobenzidine Map detection kit (Ventana). Antigen
retrieval was achieved with a 4 minute incubation of Protease 2
(Ventana). Afterward, slides were incubated for 1 h at 37uC with
mouse monoclonal anti-tenascin C (B28-13; 1:50). Slides were
then treated for 32 min at 37uC with a biotinylated universal
secondary antibody (Ventana) and counterstained with hematox-
ylin and bluing reagent (Ventana).
Western blot
Proteins (70 mg) from 2D fibroblast cultures were separated
using a 12% SDS-PAGE, transferred onto polyvinyl difluoride
membrane and probed with the rabbit polyclonal anti-SDF1 alpha
(alias CXCL12) antibody (ab9797, Abcam, Cambridge, UK, 1/
200). Membranes were then reprobed using the mouse monoclo-
nal anti-GAPDH antibody (ab9484, Abcam,Cambridge, UK, 1/
5000). Blots were revealed using electrochemiluminescence
(ECL+) reagents (GE Healthcare, London, UK). The amount of
CXCL12 was quantified, relative to that of GAPDH in a
genegnome device, using the genetools software (Ozyme, Mon-
tigny-le-Bretonneux, France).
Supporting Information
Figure S1 Cluster analysis of differentially expressed genes
between the missense and the nonsense pools. Shown is the 2D
cluster analysis of the ANOVA results of the microarray data (with
p,10
210 as threshold). The log(ratio) for each slides of the dye-
swap for the missense and nonsense pools are illustrated in red
when the mRNAs are over-represented in the NBCCS pool
compare to the control pool and conversely in green. The slides
‘‘missense and nonsense pools’’ marked with an asterisk (*) were
incubated with Cy5 for the control target and Cy3 for the NBCCS
target, and reciprocally for the slides without asterisk. Details on
the genes and the ratios of intensity between NBCCS and control
pools are included in Table S3.
Found at: doi:10.1371/journal.pone.0004818.s001 (0.01 MB
PDF)
Table S1 Common NBCCS signature of the microarray results:
308 genes differentially expressed (p,10
25) in the two NBCCS
pools compared to the control pool. The microarray assay was
performed in dye-swap. The results of the dye-swaps were
combined for the missense and the nonsense pools. For each
gene or sequence, the fold change and its associated p-value are
mentioned. Positive fold changes stand for an increased expression
in NBCCS pool; negative fold changes stand for a decreased
expression in NBCCS pool.
Found at: doi:10.1371/journal.pone.0004818.s002 (0.02 MB
PDF)
Table S2 Anti-correlated genes between the missense and the
nonsense pools. List of the genes up-regulated in one NBCCS pool
and down regulated in the other among the genes with differential
expression in NBCCS pools compare to the control pool
(p,10
25). For each gene, the fold change and its associated p-
value are mentioned. Positive fold changes stand for an increased
expression in NBCCS pool; negative fold changes stand for a
decreased expression in NBCCS pool.
Found at: doi:10.1371/journal.pone.0004818.s003 (0.01 MB
PDF)
Table S3 38 differentially expressed genes between the missense
and the nonsense pools found by analysis of variance of the
microarray results. For each slide of the dye-swaps, the fold change
between NBCCS and control pools are indicated for the 38 genes
differentially expressed between the two NBCCS pools. Positive
fold changes stand for an increased expression in NBCCS pools;
negative fold changes stand for a decreased expression in NBCCS
pools. The slides ‘‘missense and nonsense pools’’ marked with an
asterisk (*) were incubated with Cy5 for the control target and Cy3
for the NBCCS target, and reciprocally for the slides without
asterisk.
Found at: doi:10.1371/journal.pone.0004818.s004 (0.01 MB
PDF)
Table S4 Primers used for quantitative real-time PCR. List of
the TaqManH Gene Expression Assays primers used for Q-PCR
(Applied Biosystems, Foster City, USA, CA).
Found at: doi:10.1371/journal.pone.0004818.s005 (0.01 MB
PDF)
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